5HTTLPR and rs-25,531 polymorphisms significantly influenced escitalopram efficacy, and patients carrying LL genotypes with LALA haplotype and 2 L functional group have better treatment response to escitalopram therapy compared to other groups.
Afridi et al. (Wed,) studied this question.